July 27 (Reuters) – Amgen Inc on Wednesday reported
higher-than-expected second-quarter profit on increased sales of
its blockbuster rheumatoid arthritis drug Enbrel and newer
medicines, and the …
The post UPDATE 2-Amgen again raises 2016 forecast in display of confidence appeared first on NASDAQ.